VeriMomIst chitosan lauramide succinamide in der Schwangerschaft sicher?
No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
Related ingredients
Frequently asked questions
- Ist chitosan lauramide succinamide in der Schwangerschaft sicher?
- No harmonised CLP classification (no H360/H361) or SCCS/CIR safety assessment was found for this specific INCI. The ingredient is listed in the EU cosmetic ingredient inventories (CosIng / Official Journal list) as a cosmetic chitosan derivative but I found no reproductive toxicity or human teratogenicity data for this specific derivative. General chitosan/chitosan-oligosaccharide literature does not indicate established teratogenicity. Sources: EU ingredient listing, EWG entry, and PubMed review of chitosan oligosaccharides (no adverse reproductive signal).
- Ist chitosan lauramide succinamide während des Stillens sicher?
- No data located indicating reproductive or lactation-related hazard, no harmonised classification, and no SCCS/CIR contraindication for breastfeeding. Topical cosmetic use of polymeric chitosan derivatives typically shows low systemic absorption; no studies found showing transfer into breast milk for this derivative.
- Ist chitosan lauramide succinamide sicher für Babyhaut?
- No specific infant-skin safety or absorption studies were located for chitosan lauramide succinamide. Following your scoring rules, because there is measurable (but low) potential for topical absorption for modified chitosan derivatives and infants have higher surface-area-to-weight and immature barrier, exposure (e) is increased by +1 vs adult (from 0 to 1). No infant-specific hazard or mechanism evidence was found to raise h or m.
- Wie bewertet VeriMom chitosan lauramide succinamide?
- VeriMom bewertet chitosan lauramide succinamide mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu chitosan lauramide succinamide?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu chitosan lauramide succinamide basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.